Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexia Iasonos

Showing results (21-30 of 269) with videos related to

Pageof 27
Sort By:
Contemporary Clinical Trials|December 16, 2022
Controlled amplification in oncology dose-finding trialsHakim-Moulay Dehbi, John O'Quigley, Alexia Iasonos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2015
Scientific Review of Phase I Protocols With Novel Dose-Escalation Designs: How Much Information Is Needed?Alexia Iasonos, Mithat Gönen, George J Bosl
Journal of the Royal Statistical Society. Series C, Applied Statistics|August 26, 2022
Phase I clinical trials in adoptive T-cell therapiesSean M Devlin, Alexia Iasonos, John O'Quigley
Statistical Methods in Medical Research|December 24, 2021
Stopping rules for phase I clinical trials with dose expansion cohortsSean M Devlin, Alexia Iasonos, John O'Quigley
Genetic Epidemiology|September 10, 2015
Prognostic and Predictive Values and Statistical Interactions in the Era of Targeted TreatmentJaya M Satagopan, Alexia Iasonos, Qin Zhou
Contemporary Clinical Trials|November 8, 2021
Controlled backfill in oncology dose-finding trialsHakim-Moulay Dehbi, John O'Quigley, Alexia Iasonos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2016
Reply to M.P. Decatris et alDavid M Hyman, David B Solit, Alexia Iasonos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 27, 2019
Ethical and Policy Issues for Seamless Phase I Oncology TrialsNora Hutchinson, Esther Vinarov, Alexia Iasonos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Picking the Right Patient for Human Epidermal Growth Factor Receptor 3-Targeted Therapy in Platinum-Resistant Ovarian CancerAlison M Schram, Alexia Iasonos, David M Hyman
Statistical Methods in Medical Research|August 19, 2024
New clinical trial design borrowing information across patient subgroups based on fusion-penalized regression modelsMarion Kerioui, Alexia Iasonos, Mithat Gönen, et al.
Pageof 27

Showing results (21-30 of 269) with videos related to

Sort By:
Pageof 27
Contemporary Clinical Trials|December 16, 2022
Controlled amplification in oncology dose-finding trialsHakim-Moulay Dehbi, John O'Quigley, Alexia Iasonos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2015
Scientific Review of Phase I Protocols With Novel Dose-Escalation Designs: How Much Information Is Needed?Alexia Iasonos, Mithat Gönen, George J Bosl
Journal of the Royal Statistical Society. Series C, Applied Statistics|August 26, 2022
Phase I clinical trials in adoptive T-cell therapiesSean M Devlin, Alexia Iasonos, John O'Quigley
Statistical Methods in Medical Research|December 24, 2021
Stopping rules for phase I clinical trials with dose expansion cohortsSean M Devlin, Alexia Iasonos, John O'Quigley
Genetic Epidemiology|September 10, 2015
Prognostic and Predictive Values and Statistical Interactions in the Era of Targeted TreatmentJaya M Satagopan, Alexia Iasonos, Qin Zhou
Contemporary Clinical Trials|November 8, 2021
Controlled backfill in oncology dose-finding trialsHakim-Moulay Dehbi, John O'Quigley, Alexia Iasonos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2016
Reply to M.P. Decatris et alDavid M Hyman, David B Solit, Alexia Iasonos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 27, 2019
Ethical and Policy Issues for Seamless Phase I Oncology TrialsNora Hutchinson, Esther Vinarov, Alexia Iasonos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Picking the Right Patient for Human Epidermal Growth Factor Receptor 3-Targeted Therapy in Platinum-Resistant Ovarian CancerAlison M Schram, Alexia Iasonos, David M Hyman
Statistical Methods in Medical Research|August 19, 2024
New clinical trial design borrowing information across patient subgroups based on fusion-penalized regression modelsMarion Kerioui, Alexia Iasonos, Mithat Gönen, et al.
Pageof 27